Noorwegen - Noors - Statens legemiddelverk

ge healthcare b.v. - natriumjodid (123i) - kapsel, hard

Noorwegen - Noors - Statens legemiddelverk

ge healthcare b.v. - natriumjodid (123i) - injeksjonsvæske, oppløsning - 37 mbq/ ml

Noorwegen - Noors - Statens legemiddelverk

curium netherlands b.v. - natriumjodid (123i) - injeksjonsvæske, oppløsning - 37 mbq/ ml

Noorwegen - Noors - Statens legemiddelverk

ge healthcare buchler gmbh & co. kg - tauroselkolsyre - kapsel, hard - 370 kbq

Noorwegen - Noors - Statens legemiddelverk

curium netherlands b.v. - natriummolybdat mo-99 omdannet til natriumperteknetat tc-99m - radionuklidegenerator

Noorwegen - Noors - Statens legemiddelverk

pfizer as - ziprasidonhydrokloridmonohydrat - kapsel, hard - 80 mg

Noorwegen - Noors - Statens legemiddelverk

pfizer as - ziprasidonhydrokloridmonohydrat - kapsel, hard - 20 mg

Europese Unie - Noors - EMA (European Medicines Agency)

janssen-cilag international n.v.    - amivantamab - karsinom, ikke-småcellet lunge - antineoplastiske midler - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.

Europese Unie - Noors - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - multippelt myelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.